Search Results - "Hindmarsh, Elizabeth J"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2

    Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor by Browne, Cecille D, Hindmarsh, Elizabeth J, Smith, Jeffrey W

    Published in The FASEB journal (01-10-2006)
    “…Orlistat, an antiobesity drug, is cytostatic and cytotoxic to tumor cells (1). The antitumor activity of orlistat can be attributed to its ability to inhibit…”
    Get full text
    Journal Article
  3. 3

    Complement Activation Occurs on Subendothelial Extracellular Matrix In Vitro and Is Initiated by Retraction or Removal of Overlying Endothelial Cells by Hindmarsh, Elizabeth J, Marks, Rory M

    Published in The Journal of immunology (1950) (15-06-1998)
    “…Vascular endothelium is continuously exposed to plasma complement, which could generate a potent proinflammatory signal if activated on the vascular wall…”
    Get full text
    Journal Article
  4. 4

    Treatment of central nervous system inflammation with inhibitors of basement membrane degradation by Parish, Christopher R, Hindmarsh, Elizabeth J, Bartlett, Mark R, Staykova, Maria A, Cowden, William B, Willenborg, David O

    Published in Immunology and cell biology (01-02-1998)
    “…Currently available anti‐inflammatory drugs for the treatment of multiple sclerosis (MS) and other inflammatory diseases are generally inadequate, with disease…”
    Get full text
    Journal Article
  5. 5

    Cell surface expression of the 300 kDa mannose-6-phosphate receptor by activated T lymphocytes by Hindmarsh, Elizabeth J, Staykova, Maria A, Willenborg, David O, Parish, Christopher R

    Published in Immunology and cell biology (01-10-2001)
    “…Phosphosugars, such as mannose‐6‐phosphate (M6P), have been shown previously to display anti‐inflammatory properties, notably inhibition of experimental…”
    Get full text
    Journal Article
  6. 6

    Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis by Li, Rachel W., Freeman, Craig, Yu, Di, Hindmarsh, Elizabeth J., Tymms, Kathleen E., Parish, Christopher R., Smith, Paul N.

    Published in Arthritis and rheumatism (01-06-2008)
    “…Objective Although heparanase is recognized as a proangiogenic factor, the involvement of heparanase in rheumatoid arthritis (RA) is unclear. In this study, we…”
    Get full text
    Journal Article
  7. 7

    5-Aminoimidazole-4-carboxamide ribotide transformylase-IMP cyclohydrolase from human CCRF-CEM leukemia cells: purification, pH dependence, and inhibitors by Szabados, Eve, Hindmarsh, Elizabeth J, Phillips, Leonidas, Duggleby, Ronald G, Christopherson, Richard I

    Published in Biochemistry (Easton) (01-11-1994)
    “…The bifunctional enzyme 5-aminoimidazole-4-carboxamide ribotide (AICAR) transformylase-IMP cyclohydrolase has been purified 780-fold to apparent homogeneity…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Decay‐accelerating factor is a component of subendothelial extracellular matrix in vitro, and is augmented by activation of endothelial protein kinase C by Hindmarsh, Elizabeth J., Marks, Rory M.

    Published in European journal of immunology (01-03-1998)
    “…The vasculature is protected from complement activation by regulatory molecules expressed on endothelial cells. However, complement fixation also occurs on…”
    Get full text
    Journal Article
  10. 10